The assay development of a molecular marker for transmissible spongiform encephalopathies
- 1 January 1997
- journal article
- Published by Wiley in Electrophoresis
- Vol. 18 (3-4) , 502-506
- https://doi.org/10.1002/elps.1150180327
Abstract
The transmissible spongiform encephalopathies are a group of neurodegenerative diseases which include Creutzfeldt‐Jakob disease (CJD) in humans, scrapie in sheep, and bovine spongiform encephalopathy (BSE) in cattle. Two‐dimensional electrophoresis of proteins was previously used to identify two marker proteins, 130/131, which are selectively present in the cerebrospinal fluid (CSF) of patients with CJD and not in patients with other dementias. The recent characterization of these proteins by amino acid sequencing has identified them as members of the 14‐3‐3 family of proteins. Polyclonal antibodies against 14‐3‐3 (all isoforms), 14‐3‐3γ, 14‐3‐3β, and 14‐3‐3θ are immunoreactive with a 30 kDa marker band from CJD CSF. Silver staining of two‐dimensional electrophoresis separated BSE CSF proteins does not identify a similar marker. However, 14‐3‐3 immunoreactivity is found in cattle CSF when these proteins are blotted to polyvinylidene difluoride but not when blotted to nitrocellulose.Keywords
This publication has 7 references indexed in Scilit:
- The 14-3-3 Brain Protein in Cerebrospinal Fluid as a Marker for Transmissible Spongiform EncephalopathiesNew England Journal of Medicine, 1996
- Premortem diagnosis of Creutzfeldt-Jakob disease by cerebrospinal fluid analysisThe Lancet, 1996
- 14-3-3 proteins: biological function and domain structureBiochemical Society Transactions, 1995
- Subcellular Localisation of 14‐3‐3 Isoforms in Rat Brain Using Specific AntibodiesJournal of Neurochemistry, 1994
- Fatal Familial Insomnia, a Prion Disease with a Mutation at Codon 178 of the Prion Protein GeneNew England Journal of Medicine, 1992
- Simultaneous analysis of phosphoproteins and total cellular proteins from PC12 cellsMethods, 1991
- Abnormal Proteins in the Cerebrospinal Fluid of Patients with Creutzfeldt–Jakob DiseaseNew England Journal of Medicine, 1986